Re-Excision Rate in Breast Conservation Surgery after Neoadjuvant Chemotherapy
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: The purpose of this study was to compare the success rate of re-excision and breast-conserving surgery (BCS) between patients who received neoadjuvant chemotherapy and those who did not. Methods: In this retrospective cohort study, 256 women who had clinical T2 breast cancer and planned to receive, as initial treatment either BCS (n=197) or neoadjuvant chemotherapy (n=59) between January 2009 and December 2012 were included. The data, including age, initial tumor size, mammographic microcalcification, ultrasound multifocality and axillary nodal status, were collected. The pathologic tumor size, p-multifocality, histologic type, estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2, Ki-67, ductal carcinoma in situ (DCIS) and extensive intraductal component (EIC) were also reviewed. The re-excision and BCS success rates were investigated. Univariate analysis and regression model were used. To reduce the effect of selection bias, propensity score matching-based analysis was also performed. Results: Of the 256 patients, 178 patients (90.4%, 178/197) in the non-neoadjuvant group and 56 patients (94.9%, 56/59) in the neoadjuvant group received BCS (p=0.406). In propensity-matched cohorts (n=118), the re-excision rate was similar in the two groups (35.6% in neoadjuvant group vs. 35.6% in non-neoadjuvant group, p=1.000). BCS success rate was slightly higher in neoadjuvant group (94.9%, 56/59) than in non-neoadjuvant group (86.4% [51/59], p=0.205). In logistic regression model, clinicopathologic factors associated with re-excision were pathologic multifocality (odds ratio [OR], 4.56; p=0.0142), high Ki-67 (≥50%) (OR, 0.7; p=0.0243) and DCIS component (OR, 2.67; p=0.0261). Conclusion: This study showed that neoadjuvant chemotherapy could increase the success rate of BCS but could not decrease that of re-excision. The re-excision rate is more associated with pathologic finding rather than the effect of neoadjuvant chemotherapy.
Abstract
Purpose: The purpose of this study was to compare the success rate of re-excision and breast-conserving surgery (BCS) between patients who received neoadjuvant chemotherapy and those who did not. Methods: In this retrospective cohort study, 256 women who had clinical T2 breast cancer and planned to receive, as initial treatment either BCS (n=197) or neoadjuvant chemotherapy (n=59) between January 2009 and December 2012 were included. The data, including age, initial tumor size, mammographic microcalcification, ultrasound multifocality and axillary nodal status, were collected. The pathologic tumor size, p-multifocality, histologic type, estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2, Ki-67, ductal carcinoma in situ (DCIS) and extensive intraductal component (EIC) were also reviewed. The re-excision and BCS success rates were investigated. Univariate analysis and regression model were used. To reduce the effect of selection bias, propensity score matching-based analysis was also performed. Results: Of the 256 patients, 178 patients (90.4%, 178/197) in the non-neoadjuvant group and 56 patients (94.9%, 56/59) in the neoadjuvant group received BCS (p=0.406). In propensity-matched cohorts (n=118), the re-excision rate was similar in the two groups (35.6% in neoadjuvant group vs. 35.6% in non-neoadjuvant group, p=1.000). BCS success rate was slightly higher in neoadjuvant group (94.9%, 56/59) than in non-neoadjuvant group (86.4% [51/59], p=0.205). In logistic regression model, clinicopathologic factors associated with re-excision were pathologic multifocality (odds ratio [OR], 4.56; p=0.0142), high Ki-67 (≥50%) (OR, 0.7; p=0.0243) and DCIS component (OR, 2.67; p=0.0261). Conclusion: This study showed that neoadjuvant chemotherapy could increase the success rate of BCS but could not decrease that of re-excision. The re-excision rate is more associated with pathologic finding rather than the effect of neoadjuvant chemotherapy.
참고문헌 (23)
- van Maaren MC, "10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study", Lancet Oncol, 17, pp.1158~1170 (2016)
- Ye JC, "Equivalent survival with mastectomy or breast-conserving surgery plus radiation in young women aged < 40 years with early-stage breast cancer: a national registry-based stage-by-stage comparison", Clin Breast Cancer, 15, pp.390~397 (2015)
- Agarwal S, "Effect of breast conservation therapy vs mastectomy on disease-specific survival for early-stage breast cancer", JAMA Surg, 149, pp.267~274 (2014)
- Veronesi U, "Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer", N Engl J Med, 347, pp.1227~1232 (2002)
- Russo AL, "Margin status and the risk of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy", Breast Cancer Res Treat, 140, pp.353~361 (2013)
- Groot G, "Predicting local recurrence following breast-conserving therapy for early stage breast cancer: the significance of a narrow (≤ 2 mm) surgical resection margin", J Surg Oncol, 103, pp.212~216 (2011)
- Jobsen JJ, "The impact of margin status in breast-conserving therapy for lobular carcinoma is age related", Eur J Surg Oncol, 36, pp.176~181 (2010)
- Gogescu G, "Conserving surgery: balance between good cosmetic aspect and local disease control in incipient breast cancer", Chirurgia (Bucur), 109, pp.461~470 (2014)
- Bulam H, "Cosmetic outcome and percentage of breast volume excision in oncoplastic breast-conserving surgery: a proposal", World J Surg, 34, pp.2260~ (2010)
- Volders JH, "Neoadjuvant chemotherapy in breast-conserving surgery: consequences on margin status and excision volumes: a nationwide pathology study", Eur J Surg Oncol, 42, pp.986~993 (2016)
- Vergine M, "Breast-conserving surgery after neoadjuvant chemotherapy in patients with locally advanced cancer. Preliminary results", G Chir, 34, pp.254~256 (2013)
- Cho JH, "Oncologic safety of breast-conserving surgery compared to mastectomy in patients receiving neoadjuvant chemotherapy for locally advanced breast cancer", J Surg Oncol, 108, pp.531~536 (2013)
- Peintinger F, "The safety of breast-conserving surgery in patients who achieve a complete pathologic response after neoadjuvant chemotherapy", Cancer, 107, pp.1248~1254 (2006)
- Fisher B, "Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18", J Clin Oncol, 15, pp.2483~2493 (1997)
- van der Hage JA, "Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902", J Clin Oncol, 19, pp.4224~4237 (2001)
- Bonadonna G, "Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute", J Clin Oncol, 16, pp.93~100 (1998)
- Christy CJ, "Preoperative chemotherapy decreases the need for re-excision of breast cancers between 2 and 4 cm diameter", Ann Surg Oncol, 16, pp.697~702 (2009)
- Karanlik H, "Preoperative chemotherapy for T2 breast cancer is associated with improved surgical outcome", Eur J Surg Oncol, 41, pp.1226~1233 (2015)
- Soucy G, "Surgical margins in breast-conservation operations for invasive carcinoma: does neoadjuvant chemotherapy have an impact?", J Am Coll Surg, 206, pp.1116~1121 (2008)
- Yang T, "Shrinkage mode of the primary breast tumor after neoadjuvant chemotherapy analyzed with part-mount sub-serial sectioning and three-dimensional reconstruction technique", Zhonghua Zhong Liu Za Zhi, 38, pp.270~276 (2016)
- Gatek J, "Significance of the resection margin and risk factors for close or positive resection margin in patients undergoing breast-conserving surgery", J BUON, 17, pp.452~456 (2012)
- Tartter PI, "Factors associated with clear biopsy margins and clear reexcision margins in breast cancer specimens from candidates for breast conservation", J Am Coll Surg, 185, pp.268~273 (1997)
- Smitt MC, "Association of clinical and pathologic variables with lumpectomy surgical margin status after preoperative diagnosis or excisional biopsy of invasive breast cancer", Ann Surg Oncol, 14, pp.1040~1044 (2007)